Goat Anti-Mouse IL-31 RA Polyclonal Antibody, Biotin Conjugated from R&D Systems
...bore tubes to 1 outflow Single-cell and patch del...several millisecond) solution change Very small d...ion , Solid construction 360, 250 and 100 micr...any micromanipulator Available in 4, 8, and 16 ch...
...e cells (BTI-TN-5B1-4) derived from Trichoplusia n...le of expressing significantly higher levels of se...ct cells. High Five cells offer the following feat...Quick adaptation into serum-free medium- Up to 25-...
...atile Promega Flipper® Racks are ideal for sto...se polypropylene racks withstand extreme temperatu...torage. They may also be autoclaved for use in ste...e accommodates 0.5ml microcentrifuge tubes, the ot...
Biology Products:(Date:11/19/2009)..., NEW YORK, Nov. 19 Ne...at it has sent the following letter to its shareho...tober 30, 2009, of China Biopharmaceuticals Holdin...company based in the People,s Republic of China. T... in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s pr...
(Date:11/19/2009)..., MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therap...t patient in a randomized Phase 2B study of AEG351...development for multiple oncology indications. ,...hase 2 Study of the X-Linked Inhibitor of Apoptosi...ith High-dose Cytarabine and Idarubicin in AML Fol...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswi...ne program on one product candidate at an unexpect...date AD02 is planned to enter into,Phase II clinic...ny,immediately follows the completion of two Phase...ompany based its fast decision on the first interi...
(Date:11/18/2009)...MPAIGN, Ill. Imagine a polka-dotted postage stamp...ns simply by changing colors. , As reported in t... , Kenneth Suslick and his team at the University ...the general detection of toxic industrial chemical... works by visualizing odors. This sensor array co...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3